MedPath

CLINICAL STUDY TO EVALUATE THE EFFICACY OF SUVARNAPRASHANA ON GROWTH & DEVELOPMENT ALONG WITH ITS EFFECT ON MORBIDITY STATUS IN 0-5 YEAR AGE CHILDRE

Phase 2
Registration Number
CTRI/2023/03/050249
Lead Sponsor
DR S R RAJASTHAN AYURVED UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children of 0-5 year of age will be selected in study

2.Children having recurrent episodes of fever, running nose, cold, cough, abdominal pain, nausea, vomiting, loose stools, abdominal distension and constipation will be considered in the study.

Exclusion Criteria

1.Children above 5 year of age will be excluded.

2.Children showing sign of delayed growth & development will be excluded in the study due to any organic lesion.

3.Children having hypersensitivity to gold, honey & ghrita will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improve growth and development and nutrition of children of 0 - 5 age group.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Minimized the morbidity status in children of 0-5 year age group through Suvarnaprashana.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath